NCT06866132View on ClinicalTrials.gov

Response to an Investigational Device in Patients With Restless Legs Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

August 4, 2025

Study Completion Date

September 30, 2025

Conditions
Restless Legs Syndrome
Interventions
DEVICE

Investigational Noninvasive Neuromodulation Device

The investigational noninvasive neuromodulation device will be setup by the patient at bedtime and will be used every night. The IRB has established that the investigational device is non-significant risk.

Trial Locations (1)

94566

Noctrix Health Headquarters, Pleasanton

Sponsors
All Listed Sponsors
lead

Noctrix Health, Inc.

INDUSTRY

NCT06866132 - Response to an Investigational Device in Patients With Restless Legs Syndrome | Biotech Hunter | Biotech Hunter